Sept 2011: Kuros completes patient recruitment in a Phase IIb clinical trial with KUR-211 for diabetic foot ulcers (auf Deutsch).
Zurich, Switzerland, 1 September, 2011 - Kuros Biosurgery AG, a biotechnology company focused on the...

Aug 2011: Kuros completes patient recruitment in its European clinical study of KUR-023, its novel dural sealant product candidate (auf Deutsch).
Zurich, Switzerland, 17 August 2011 - Kuros Biosurgery AG, a biotechnology company focused on the...

July 2011: Kuros announces allowance of US patent for the local application of PTH (auf Deutsch).
Zurich, Switzerland, 19th July 2011 - Kuros Biosurgery AG, a biotechnology company focused on the...